Value of chest radiography in predicting treatment response in children aged 3-59 months with severe pneumonia

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 11, 2008, Pages 1320-1326

  Patel, A ^a   Mamtani, M ^a   Hibberd, P L ^b   Tuan, T A ^c   Jeena, P ^d   Chisaka, N ^e   Hassan, M ^f   Maulen Radovan, I ^g   Thea, D M ^h   Qazi, S ⁱ   Kulkarni, Hemant ^a,j  

^a Lata Medical Research Foundation   (India)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Children's Hospital No 1   (Viet Nam)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e Tropical Diseases Research Centre Ndola   (Zambia)

^f Children Hospital Islamabad   (Pakistan)

^g HOSPITAL ÁNGELES LOMAS   (Mexico)

^h BOSTON UNIVERSITY   (United States)

ⁱ WORLD HEALTH ORGANIZATION   (Switzerland)

^j NONE   (United States)

more..

Author keywords

Radiography; Severe pneumonia; Treatment failure

Indexed keywords

AMOXICILLIN; PENICILLIN G;

ADOLESCENT; ARTICLE; BACTERIUM CULTURE; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GROUPS BY AGE; HAEMOPHILUS INFLUENZAE; HIGH RISK PATIENT; HUMAN; INFANT; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; NASOPHARYNGEAL ASPIRATION; PENICILLIN RESISTANCE; PLEURA FLUID; PNEUMONIA; POISSON DISTRIBUTION; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SEVERE PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; TERTIARY HEALTH CARE; THORAX RADIOGRAPHY; TREATMENT FAILURE; TREATMENT RESPONSE; WORLD HEALTH ORGANIZATION;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; FEMALE; HUMANS; INFANT; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PENICILLINS; PNEUMONIA; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SINGLE-BLIND METHOD; TREATMENT FAILURE;

EID: 56249133020     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Multicentre Amoxycillin Short Course Therapy (MASCOT) Pneumonia Study Group. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet 2002; 360: 835-841.
2. CATCHUP (Cotrimoxazole Amoxicillin Trial in Children Under 5 Years for Pneumonia) Study Group. Clinical efficacy of cotrimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomised controlled clinical trial in Pakistan. Arch Dis Child 2002; 86: 113-118.
3. Addo-Yobo E, Chisaka N, Hassan M, et al. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study. Lancet 2004; 364: 1141-1148.
4. Agarwal G, Awasthi S, Kabra S K, Kaul A, Singhi S, Walter S D. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. BMJ 2004; 328: 791.
5. Duke T, Poka H, Dale F, Michael A, Mgone J, Wal T. Chloramphenicol versus benzylpenicillin and gentamicin for the treatment of severe pneumonia in children in Papua New Guinea: a randomised trial. Lancet 2002; 359: 474-480.
6. Noorani Q A, Qazi S A, Rasmussen Z A, et al. Response to cotrimoxazole in the management of childhood pneumonia in first-level health care facilities. Int J Tuberc Lung Dis 2006; 10: 932-938.
7. Rasmussen Z A, Bari A, Qazi S, et al. Randomised controlled trial of standard versus double dose cotrimoxazole for childhood pneumonia in Pakistan. Bull World Health Organ 2005; 83: 10-19.
8. Shann F, Barker J, Poore P. Chloramphenicol alone versus chloramphenicol plus penicillin for severe pneumonia in children. Lancet 1985; 2: 684-686.
9. Straus W L, Qazi S A, Kundi Z, Nomani N K, Schwartz B. Antimicrobial resistance and clinical effectiveness of cotrimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Pakistan Cotrimoxazole Study Group. Lancet 1998; 352: 270-274.
10. Ayieko P, English M. Case management of childhood pneumonia in developing countries. Pediatr Infect Dis J 2007; 26: 432-440.
11. Fu LY, Ruthazer R, Wilson I, et al. Brief hospitalization and pulse oximetry for predicting amoxicillin treatment failure in children with severe pneumonia. Pediatrics 2006; 118: e1822-e1830.
12. World Health Organization. WHO programme for the control of acute respiratory infections: acute respiratory infections in children: case management in small hospitals in developing countries. WHO/ARI/90.5. Geneva, Switzerland: WHO, 1990.
13. Hazir T, Qazi S A, Bin Nisar Y, et al. Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in Pakistan. Arch Dis Child 2007; 92: 291-297.
14. Hazir T, Qazi S A, Nisar Y B, et al. Can WHO therapy failure criteria for non-severe pneumonia be improved in children aged 2-59 months? Int J Tuberc Lung Dis 2006; 10: 924-931.
15. Davies H D, Wang E E, Manson D, Babyn P, Shuckett B. Reliability of the chest radiograph in the diagnosis of lower respiratory infections in young children. Pediatr Infect Dis J 1996; 15: 600-604.
16. Swingler G H. Observer variation in chest radiography of acute lower respiratory infections in children: a systematic review. BMC Med Imaging 2001; 1: 1.
17. Cherian T, Mulholland E K, Carlin J B, et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ 2005; 83: 353-359.
18. Patel A, Amin A, Sortey S Z, Athavale A, Kulkarni H. Impact of training on observer variation in chest radiographs of children with severe pneumonia. Indian Pediatr 2007; 44: 675-681.
19. Forrest K V, Jorgensen J H, Murray P R. Manual of clinical microbiology. 8th ed. Washington DC, USA: American Society for Microbiology, 2003.
20. Mastro T D, Nomani N K, Ishaq Z, et al. Use of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in Pakistan for surveillance for antimicrobial resistance. Pediatr Infect Dis J 1993; 12: 824-830.
21. Mufson M A, Chan G, Stanek R J. Penicillin resistance not a factor in outcome from invasive Streptococcus pneumoniae community-acquired pneumonia in adults when appropriate empiric therapy is started. Am J Med Sci 2007; 333: 161-167.
22. Deeks S L, Palacio R, Ruvinsky R, et al. Risk factors and course of illness among children with invasive penicillin-resistant Streptococcus pneumoniae. The Streptococcus pneumoniae Working Group. Pediatrics 1999; 103: 409-413.
23. Rios A M, de la Hoz F, Leal A L, et al. The impact of antimicrobial resistance and Streptococcus pneumoniae serotype distribution on the mortality of children under 5 years of age with invasive disease. Rev Panam Salud Publica 1999; 5: 69-76.
24. Sivit C J, Miller C R, Rakusan T A, Ellaurie M, Kushner D C. Spectrum of chest radiographic abnormalities in children with AIDS and Pneumocystis carinii pneumonia. Pediatr Radiol 1995; 25: 389-392.
25. World Health Organization. Programme for the control of acute respiratory infections. Report of a meeting of the Radiology Working Group, Geneva 27-28 October 1989. WHO/ARI/90.13. Geneva, Switzerland: WHO, 1990.
26. Hazir T, Nisar Y B, Qazi S A, et al. Chest radiography in children aged 2-59 months diagnosed with non-severe pneumonia as defined by World Health Organization: descriptive multicentre study in Pakistan. BMJ 2006; 333: 629.